155 related articles for article (PubMed ID: 16633111)
1. Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
Hrstic I; Huic D; Bilusic M; Vucelic B
J Clin Gastroenterol; 2006 Apr; 40(4):367-8. PubMed ID: 16633111
[No Abstract] [Full Text] [Related]
2. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
Ennaifer R; Cheikh M; Romdhane H; Hefaiedh R; Ben Nejma H; Bel Hadj N
Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173
[No Abstract] [Full Text] [Related]
3. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients.
Kasahara A
J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413
[No Abstract] [Full Text] [Related]
4. Interferon-induced haemolytic anaemia in hepatitis C.
Al-Ansari M; Weilert F; Dickson G
N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
[No Abstract] [Full Text] [Related]
5. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin.
Vilar FC; Castro Gd; Moya MJ; Martinelli Ade L; De Santis GC; Cozac AP; Figueiredo JF
Rev Soc Bras Med Trop; 2007; 40(6):678-80. PubMed ID: 18200424
[TBL] [Abstract][Full Text] [Related]
6. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
Deutsch M; Koskinas J; Tzannos K; Vassilopoulos D; Mailis A; Tolis G; Hadziyannis S
Ann Pharmacother; 2005 Oct; 39(10):1745-8. PubMed ID: 16159996
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune hemolytic anemia in a case of chronic hepatitis type C 56 weeks after initiation of second line treatment with pegylated interferon alpha2b/ribavirin combination therapy].
Nishino R; Ikeda N; Unoura M
Nihon Shokakibyo Gakkai Zasshi; 2011 Sep; 108(9):1571-8. PubMed ID: 21891998
[TBL] [Abstract][Full Text] [Related]
8. Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin.
Sykia A; Gigi E; Sinakos E; Bibashi E; Bellou A; Raptopoulou-Gigi M
J Gastrointestin Liver Dis; 2009 Mar; 18(1):118-9. PubMed ID: 19337648
[No Abstract] [Full Text] [Related]
9. Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
Demelia L; Civolani A; Murgia D; Murru A; Sorbello O; Rizzetto M
J Hepatol; 2007 Jan; 46(1):171-3. PubMed ID: 17107736
[No Abstract] [Full Text] [Related]
10. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin.
Cauli C; Serra G; Chessa L; Balestrieri C; Scioscia R; Lai ME; Farci P
Haematologica; 2006 Jun; 91(6 Suppl):ECR26. PubMed ID: 16785129
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.
Savvas SP; Papakostas N; Giannaris M; Malaktari S; Koskinas J; Archimandritis AJ
South Med J; 2010 Jun; 103(6):585-8. PubMed ID: 20710148
[TBL] [Abstract][Full Text] [Related]
12. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
[No Abstract] [Full Text] [Related]
13. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α induced psoriatic arthritis and autoimmune hemolytic anemia during chronic hepatitis C treatment.
Oliveira TL; Caetano AZ; Belem JM; Klemz BC; Pinheiro MM
Acta Reumatol Port; 2014; 39(4):327-30. PubMed ID: 25341062
[TBL] [Abstract][Full Text] [Related]
15. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
[TBL] [Abstract][Full Text] [Related]
16. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
17. [Autoimmune hemolytic anemia presenting during treatment of chronic hepatitis C with interferon alpha].
Rizzi R; Lucarella FP; Ruggieri GB; L'Abbate M
Ann Ital Med Int; 2003; 18(2):107-10. PubMed ID: 12886829
[TBL] [Abstract][Full Text] [Related]
18. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
Bhatti A; McGarrity TJ; Gabbay R
Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
[No Abstract] [Full Text] [Related]
19. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
Lopukhova NL
Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
[No Abstract] [Full Text] [Related]
20. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
Adinolfi LE; Durante Mangoni E; Andreana A
Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
